These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7629745)

  • 21. High-performance liquid chromatographic determination of benzalkonium and naphazoline or tetrahydrozoline in nasal and ophthalmic solutions.
    Santoni G; Medica A; Gratteri P; Furlanetto S; Pinzauti S
    Farmaco; 1994 Nov; 40(11):751-4. PubMed ID: 7530451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FTIR assay method for UV inactive drug carisoprodol and identification of degradants by RP-HPLC and ESI-MS.
    Acharya PC; Vasi R; Suares D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():16-21. PubMed ID: 27398631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and structure elucidation of major alkaline degradant of ezetimibe.
    Gajjar AK; Shah VD
    J Pharm Biomed Anal; 2011 Apr; 55(1):225-9. PubMed ID: 21288678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMR.
    Awasthi A; Razzak M; Al-Kassas R; Greenwood DR; Harvey J; Garg S
    J Pharm Biomed Anal; 2012 Apr; 63():62-73. PubMed ID: 22341479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of three different phosphorescent methodologies in solution for the analysis of naphazoline in pharmaceutical preparations.
    Díaz BC; Terrones SC; Carretero AS; Fernández JM; Gutiérrez AF
    Anal Bioanal Chem; 2004 May; 379(1):30-4. PubMed ID: 14985905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate.
    Lin M; Li M; Buevich AV; Osterman R; Rustum AM
    J Pharm Biomed Anal; 2009 Oct; 50(3):275-80. PubMed ID: 19525081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural characterization of low level degradants in aztreonam injection and an innovative approach to aid HPLC method validation.
    Ye Q; Ding W; Rinaldi F; Huang Y; Miller SA; Bolgar M
    J Pharm Biomed Anal; 2016 May; 124():358-364. PubMed ID: 26991056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR.
    Yang Y; Zhu X; Zhang F; Li W; Wu Y; Ding L
    J Pharm Biomed Anal; 2016 Jun; 125():165-77. PubMed ID: 27023129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and identification of a degradation product in a capsule formulation containing the elastase inhibitor, DMP 777.
    Buckley D; Haas MJ; Scholz TH; Sigvardson KW
    J Pharm Biomed Anal; 2001 Feb; 24(4):651-7. PubMed ID: 11272322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of neem oils by LC-MS and degradation kinetics of azadirachtin-A in a controlled environment. Characterization of degradation products by HPLC-MS-MS.
    Barrek S; Paisse O; Grenier-Loustalot MF
    Anal Bioanal Chem; 2004 Feb; 378(3):753-63. PubMed ID: 14685815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a novel liquid chromatography/tandem mass spectrometry method for the determination of antazoline in human plasma: Result of ELEPHANT-I [ELEctrophysiological, pharmacokinetic and hemodynamic effects of PHenazolinum (ANTazoline mesylate)] human pharmacokinetic study.
    Giebułtowicz J; Piotrowski R; Baran J; Kułakowski P; Wroczyński P
    J Pharm Biomed Anal; 2016 May; 123():113-9. PubMed ID: 26895496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validated stability indicating RP-HPLC for quantitation of nitazoxanide in presence of its alkaline degradation products and their characterization by HPLC-tandem mass spectrometry.
    Hegazy M; Kessiba A; El Gindy AE; Abdelkawy M
    J Chromatogr Sci; 2014 Oct; 52(9):1071-81. PubMed ID: 24248557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A validated specific stability-indicating RP-HPLC assay method for the determination of loteprednol etabonate in eye drops.
    Han YK; Segall AI
    J Chromatogr Sci; 2015; 53(5):761-6. PubMed ID: 25234383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forensic Drug Identification, Confirmation, and Quantification Using Fully Integrated Gas Chromatography with Fourier Transform Infrared and Mass Spectrometric Detection (GC-FT-IR-MS).
    Lanzarotta A; Lorenz L; Voelker S; Falconer TM; Batson JS
    Appl Spectrosc; 2018 May; 72(5):750-756. PubMed ID: 29154671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a new impurity in lisinopril.
    Shinde V; Trivedi A; Upadhayay PR; Gupta NL; Kanase DG; Chikate R
    J Pharm Biomed Anal; 2007 Jan; 43(1):381-6. PubMed ID: 16926080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antazoline phosphate and naphazoline hydrochloride, singly and in combination for the treatment of allergic conjunctivitis-a controlled, double-blind clinical trial.
    Miller J; Wolf EH
    Ann Allergy; 1975 Aug; 35(2):81-6. PubMed ID: 1096685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a stability-indicating assay for nafimidone [1-(2-naphthoylmethyl)imidazole hydrochloride] by high-performance liquid chromatography.
    Taylor RB; Durham DG; Shivji AS; Reid R
    J Chromatogr; 1986 Feb; 353():51-9. PubMed ID: 3700525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.